Respiratory Devices Market - Global Trends and forecast till 2025

Respiratory Devices Market – Breathing Life into Critically ill Patients

Respiratory devices are used to mechanically supply respiratory gas or oxygen to the patients with impaired respiratory function. The currently available innovative respiratory devices automatically adjust inhalations and exhalations according to the patient’s requirement. The devices are also available in various versions such as emergency respiratory devices for rescue application, long-term respiratory devices for intensive care, and mobile home respiratory devices.

The global respiratory devices market was valued at US$ 15,143.2 million in 2016 and is expected to witness a robust CAGR of 8.8% over the forecast period (2017 - 2025).

Request a sample copy of this report:
https://www.coherentmarketinsights.com/insight/request-sample/1299

Increasing admissions of critical care patients in Intensive Care Units (ICU) is expected to fuel the market growth

Increasing prevalence of chronic respiratory diseases such as asthma, chronic pulmonary lung disease, pulmonary hypertension, and occupational lung disease are the major factors augmenting growth of the respiratory devices market, owing to the pronounced need of therapeutic respiratory devices in the medical as well as in the homecare settings. According to the World Health Organization (WHO), in 2017, asthma is a major non communicable disease with an estimated 235 million people suffering from the condition. According to the American Academy of Allergy Asthma and Immunology, 2015, an estimated number of people suffering from asthma is expected to increase by more than 100 million by 2025. North America is expected to dominate the respiratory devices market, owing to increasing number of hospitalizations and emergency visits associated with acute or life threatening medical problems. According to the study by Society of Critical Care Medicine 2016, more than 5.7 million patients are admitted annually to intensive care units (ICUs) in the U.S. for support of airway, breathing or circulation, and comprehensive management of injury. Also, According to the Centers of Disease Control and Prevention (CDC), 2017, around 1.7 million emergency department visits with chronic and unspecified bronchitis were registered in the U.S. hospital facilities. However, stringent FDA approvals, lack of awareness about innovative devices and unaffordable or high cost of respiratory devices are the factors restraining growth of the respiratory devices market.

Increasing support from international organizations for prevention of chronic respiratory diseases is expected to accelerate the market growth

Various organizations, institutions, and agencies are working towards improving the diagnosis and the medical care needed to reduce the global burden of respiratory diseases. For instance, the Global Alliance against Chronic Respiratory Diseases (GARD) was formed with the support from the World Health Organization (WHO) to control chronic respiratory diseases. GARD is a voluntary alliance of national, international organizations, and agencies from many economies. The main objective of GARD is to develop simple and affordable strategies for chronic respiratory diseases (CRD) and to encourage economies to implement health promotion and CRD prevention policies. Also, increasing birth defects such as newborn respiratory distress syndrome, cyanosis, and Broncho-pulmonary dysplasia requires the need for neonate/pediatric respiratory devices to increase the survival chances of infants. According to the Centers of Disease Control and Prevention (CDC), an estimate of 1.5 million babies were born with birth defects with about one quarter primary consultations related to respiratory complaints.

Click here to know more about this publish report: https://www.coherentmarketinsights.com/market-insight/respiratory-devices-market-1299

The major players operating the global respiratory devices market include Koninklijke Philips N.V., 3M, AstraZeneca Plc., GE Healthcare, GlaxoSmithKline Plc., Medtronic plc, Becton, Dickinson and Company, Invacare Corporation, ResMed, Inc., and CareFusion Corporation.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/

This release was published on openPR.